|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,596,545 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-05-16 |
4 |
D |
$37.78 |
$5,856 |
D/D |
(155) |
48,477 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-16 |
4 |
D |
$37.78 |
$18,512 |
D/D |
(490) |
59,384 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-05-16 |
4 |
D |
$37.78 |
$36,987 |
D/D |
(979) |
68,214 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-16 |
4 |
D |
$37.78 |
$17,039 |
D/D |
(451) |
59,344 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-16 |
4 |
S |
$37.78 |
$36,193 |
D/D |
(958) |
65,922 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-16 |
4 |
D |
$37.78 |
$17,039 |
D/D |
(451) |
62,316 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-16 |
4 |
S |
$38.09 |
$23,007 |
D/D |
(604) |
65,658 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-16 |
4 |
OE |
$15.34 |
$11,716 |
D/D |
604 |
66,262 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-05-13 |
4/A |
D |
$38.38 |
$92,576 |
D/D |
(2,412) |
285,143 |
|
- |
|
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-05-13 |
4 |
D |
$38.38 |
$9,020 |
D/D |
(235) |
48,632 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-13 |
4 |
D |
$38.38 |
$26,714 |
D/D |
(696) |
66,880 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-13 |
4 |
D |
$38.38 |
$26,714 |
D/D |
(696) |
59,795 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-13 |
4 |
D |
$38.38 |
$26,714 |
D/D |
(696) |
62,767 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-05-13 |
4 |
D |
$38.38 |
$38,151 |
D/D |
(994) |
69,193 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-05-13 |
4 |
D |
$38.38 |
$80,908 |
D/D |
(2,108) |
285,447 |
|
- |
|
Simon Howard Allan |
SVP-Human Resources |
|
2011-05-13 |
4 |
D |
$38.38 |
$20,995 |
D/D |
(547) |
44,149 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-13 |
4 |
D |
$38.38 |
$26,714 |
D/D |
(696) |
59,874 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-13 |
4 |
S |
$39.85 |
$76,425 |
D/D |
(1,918) |
65,658 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-12 |
4/A |
S |
$38.59 |
$7,250,315 |
D/D |
(187,887) |
61,576 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-12 |
4 |
OE |
$15.34 |
$195,738 |
D/D |
12,760 |
86,408 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-05-12 |
4 |
S |
$40.00 |
$5,729,080 |
D/D |
(143,227) |
22,000 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-05-12 |
4 |
OE |
$15.19 |
$2,178,352 |
D/D |
143,227 |
165,227 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-12 |
4 |
AS |
$38.59 |
$7,250,315 |
D/D |
(187,887) |
61,576 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-12 |
4 |
OE |
$9.75 |
$2,099,489 |
D/D |
163,853 |
249,463 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-12 |
4 |
S |
$38.89 |
$3,434,256 |
D/D |
(88,311) |
58,657 |
|
- |
|
772 Records found
|
|
Page 11 of 31 |
|
|